MedTrace Logo

PAP Systems Internal Clinical Studies (ICS)

NCT06173050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-24

No results posted yet for this study

Summary

This is a pre-market study for ongoing product development aiming to explore the usability and performance of the study PAP systems to guide product development.

Conditions

Interventions

DEVICE

PAP System A (with Amalfi) then PAP System B (with CLA11)

PAP System A (with Amalfi) for 7 days followed by PAP System B (with CLA11) for 7 days

DEVICE

PAP System B (with CLA11) then PAP System A (with Amalfi)

PAP System B (with CLA11) for 7 days followed by PAP System A (with Amalfi) for 7 days

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-20
Primary Completion
2024-07-22
Completion
2024-07-25

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06173050 on ClinicalTrials.gov